Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class I · High risk Terminated Initiated Nov 18, 2013 (13 years ago)

Clinimix 4.25/25 sulfite-free

Class I — High risk. Reasonable probability of serious harm or death.

Why it was recalled

Presence of Particulate Matter: Particulate matter includes wood, sodium citrate and dextrose.

Cause type: Particulate / foreign matter

Visible foreign particles - glass, metal, fibers or other material - found in the product. Particles can enter from equipment wear, containers or the process, and are dangerous in injectables. All particulate / foreign matter recalls.

What was recalled

Clinimix 4.25/25 sulfite-free (4.25% Amino Acid in 25% Dextrose) Injection, 1000 mLCLARITY Dual Chamber Container bag, Rx only. Dist: Baxter Healthcare Corporation, One Baxter Parkway, Deerfield, IL 60015. NDC: 0338-1115-04.

Affected NDC 0338-1115-04

Compare with the code on your package — it is the most precise check available.

Product details

From the FDA NDC directory, for the product code this recall names. Compare with the label on your package.

ProductStrengthForm & routeLabelerType
Clinimix E
Leucine, Phenylalanine, Lysine, Methionine, Isoleucine, Valine, Histidine, Threonine, Tryptophan, Alanine, Glycine, Arginine, Proline, Serine, Tyrosine, Sodium Acetate, Dibasic Potassium Phosphate, Magnesium Chloride, Sodium Chloride, Calcium Chloride, Dextrose
NDC 00338-1115
LEUCINE 311 mg/100mL; PHENYLALANINE 238 mg/100mL; LYSINE 247 mg/100mL; METHIONINE 170 mg/100mL; ISOLEUCINE 255 mg/100mL; VALINE 247 mg/100mL; HISTIDINE 204 mg/100mL; THREONINE 179 mg/100mL; TRYPTOPHAN 77 mg/100mL; ALANINE 880 mg/100mL; GLYCINE 438 mg/100mL; ARGININE 489 mg/100mL; PROLINE 289 mg/100mL; SERINE 213 mg/100mL; TYROSINE 17 mg/100mL; SODIUM ACETATE 297 mg/100mL; POTASSIUM PHOSPHATE, DIBASIC 261 mg/100mL; MAGNESIUM CHLORIDE 51 mg/100mL; SODIUM CHLORIDE 77 mg/100mL; CALCIUM CHLORIDE 33 mg/100mL; DEXTROSE 10 g/100mL Injection
Intravenous
Baxter Healthcare Company Rx
Recalling firm
Baxter Healthcare Corp.
Origin
IL, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-1158-2014 · FDA notice

Treat this as urgent. Class I means FDA judged there is a reasonable probability of serious harm. Find the lot number on your package; if it matches the recalled lots, do not take another dose before you have spoken to your pharmacist or prescriber - today, not next week. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other recalls by Baxter Healthcare Corp.

All 2013 recalls
Class I · High risk

Dextrose Injection

Presence of Particulate Matter: particulate matter identified as stainless steel particles in the solution.

Ongoing Particulate / foreign matter Baxter Healthcare Corporation NDC 00338-0719-06 D-0850-2026
Class II · Moderate risk

Daptomycin

CGMP Deviations

Ongoing cGMP deviation Baxter Healthcare Corporation NDC 0338-0718-12 D-0821-2026

Other particulate / foreign matter recalls from 2013

All particulate / foreign matter recalls
Class II · Moderate risk

Carisoprodol Tablets

Presence of Foreign Substance; metal particulates were visually observed in the tablets.

Terminated Particulate / foreign matter Watson Laboratories Inc NDC 0591-5513-05 D-397-2014
Class I · High risk

Lidocaine HCl Injection

Presence of Particulate Matter- Confimed customer complaint of particulates embedded in glass container and in contact with product solution.

Terminated Particulate / foreign matter Hospira Inc. NDC 0409-2066-05 D-1278-2014
Class II · Moderate risk

Propofol Injectible Emulsion

Presence of Particulate Matter: Glass defect located on the interior neck of the vial identified glass surface abrasions and visible embedded particulate matter which could result in the potential for small glass flakes or embedded metal particulate to become dislodged into the solution.

Terminated Particulate / foreign matter Hospira Inc. NDC 0409-4699-30 D-1033-2014
Class II · Moderate risk

Carisoprodol IV

Presence of Foreign Substance; heavy metals (chromium, titanium etc) and inactive components of the product were visually observed during routine stability testing.

Terminated Particulate / foreign matter Physicians Total Care, Inc. D-390-2014